Cargando…
Longitudinal treatment responsiveness on plasma neurofilament light chain and glial fibrillary acidic protein levels in neuromyelitis optica spectrum disorder
BACKGROUND: Neurofilament light chain (NfL) and glial fibrilliary acidic protein (GFAP) have been suggested to be biomarkers of the pathophysiological process of neuromyelitis optica spectrum disorders (NMOSD), but the relationship between the plasma levels of these molecules with disease activity a...
Autores principales: | Zhang, Tian-Xiang, Chen, Jing-Shan, Du, Chen, Zeng, Pei, Zhang, Huiming, Wang, Xuejiao, Liu, Ye, Huang, Zhenning, Yuan, Meng, Li, Yu-Lin, Jia, Dongmei, Shi, Fu-Dong, Zhang, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573482/ https://www.ncbi.nlm.nih.gov/pubmed/34777577 http://dx.doi.org/10.1177/17562864211054952 |
Ejemplares similares
-
Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker
por: Aktas, Orhan, et al.
Publicado: (2021) -
Glial Fibrillary Acidic Protein in Blood as a Disease Biomarker of Neuromyelitis Optica Spectrum Disorders
por: Kim, Hyunjin, et al.
Publicado: (2022) -
The Use of Serum Glial Fibrillary Acidic Protein Measurements in the Diagnosis of Neuromyelitis Optica Spectrum Optic Neuritis
por: Storoni, Mithu, et al.
Publicado: (2011) -
Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL
por: Chen, Chih-Hao, et al.
Publicado: (2020) -
Neurofilament light chain and glial fibrillary acidic protein levels in metachromatic leukodystrophy
por: Beerepoot, Shanice, et al.
Publicado: (2021)